Skip navigation
Skip navigation

Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia

Kent, Alison; Dahlstrom, Jane

Description

Objective: To examine the association between chorioamnionitis with or without funisitis and bronchopulmonary dysplasia in infants less than 30 completed weeks gestation given the current standards of antenatal steroid and surfactant use. Methods: Infants included in the study were those delivered at less than 30 completed weeks gestation from January 1996 to July 2001, identified from a prospectively managed database. Placental pathology was reviewed for the presence or absence of...[Show more]

dc.contributor.authorKent, Alison
dc.contributor.authorDahlstrom, Jane
dc.date.accessioned2015-12-13T22:37:48Z
dc.date.available2015-12-13T22:37:48Z
dc.identifier.issn1034-4810
dc.identifier.urihttp://hdl.handle.net/1885/77261
dc.description.abstractObjective: To examine the association between chorioamnionitis with or without funisitis and bronchopulmonary dysplasia in infants less than 30 completed weeks gestation given the current standards of antenatal steroid and surfactant use. Methods: Infants included in the study were those delivered at less than 30 completed weeks gestation from January 1996 to July 2001, identified from a prospectively managed database. Placental pathology was reviewed for the presence or absence of chorioamnionitis and funisitis. Infants were divided into three groups depending on degree of exposure to fetal inflammation (no inflammation, chorioamnionitis only and chorioamnionitis and funisitis). Data relating to gestational age, sex, antenatal steroid exposure, surfactant treatment, days of positive pressure ventilation and days of oxygen required were collected. Bronchopulmonary dysplasia was defined as death due to respiratory failure or any oxygen requirement at 36 weeks postmenstrual age. Results: Two hundred and forty-one infants were included in the study. The mean gestational age was 27.7 weeks and mean birthweight 1089 g. One hundred and sixty-one infants were not exposed to any in utero inflammation, 40 showed chorioamnionitis and 40 showed chorioamnionitis and funisitis. There was no significant difference between antenatal steroid and surfactant treatment between the three groups. There was no significant difference between the three groups in the development of bronchopulmonary dysplasia. Low gestational age was the most significant predictor of developing bronchopulmonary dysplasia. Conclusion: The risk of developing bronchopulmonary dysplasia is not increased following exposure to chorioamnionitis or funisitis in the context of current antenatal steroid and surfactant use. The most significant predictor for developing bronchopulmonary dysplasia is gestational age at the time of delivery.
dc.publisherBlackwell Publishing Ltd
dc.sourceJournal of Paediatrics and Child Health
dc.subjectKeywords: lung surfactant; oxygen; steroid; article; birth weight; chorioamnionitis; comparative study; controlled study; data base; death; delivery; disease association; drug use; female; gestation period; gestational age; human; infant; inflammation; intrauterine Antenatal steroids; Bronchopulmonary dysplasia; Chorioamnionitis; Placenta; Preterm infants
dc.titleChorioamnionitis/funisitis and the development of bronchopulmonary dysplasia
dc.typeJournal article
local.description.notesImported from ARIES
local.description.refereedYes
local.identifier.citationvolume40
dc.date.issued2004
local.identifier.absfor119999 - Medical and Health Sciences not elsewhere classified
local.identifier.ariespublicationMigratedxPub6160
local.type.statusPublished Version
local.contributor.affiliationKent, Alison, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationDahlstrom, Jane, College of Medicine, Biology and Environment, ANU
local.bibliographicCitation.startpage356
local.bibliographicCitation.lastpage359
local.identifier.doi10.1111/j.1440-1754.2004.00366.x
dc.date.updated2015-12-11T09:38:39Z
local.identifier.scopusID2-s2.0-3142774736
CollectionsANU Research Publications

Download

File Description SizeFormat Image
Kent_et_al-2004-Journal_of_Paediatrics_and_Child_Health.pdf73.72 kBAdobe PDFThumbnail
    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator